Cartalax 20mg bioregulator peptide
Cartalax is a short synthetic bioregulator peptide linked in the research literature to cartilage and connective tissue. Its molecular formula, C12H19N3O8, corresponds to a tripeptide. Each vial holds 20mg of lyophilised solid.
Specification
| Quantity per vial | 20mg |
|---|---|
| Molecular formula | C12H19N3O8 |
| Molecular weight | 333.29 g/mol |
| Stated purity | ≥99% (HPLC) |
| Form | Lyophilised solid |
| Storage | 2–8°C, sealed, protected from light and moisture |
Research background
Short peptides of this kind come mostly from the bioregulator research programme of Vladimir Khavinson and colleagues in St Petersburg. Cartalax has been examined in chondrocyte cultures and in studies of age-related change in connective-tissue cells. These are laboratory and preclinical findings. Cartalax is not an approved medicine.
Further reading: search PubMed for published studies on Cartalax.
Storage and handling
Keep the sealed vial at 2–8°C away from light and moisture until it is needed, and let it reach room temperature before opening to limit condensation. Your laboratory’s own procedures determine the solvent, concentration and any storage after reconstitution.
Related products
Cartalax is listed in our Bioregulator Peptides range. Related products include Bronchogen 20mg, Prostamax 20mg – Bioregulator Peptide and Ovagen 20mg – Bioregulator. For reconstitution and sample storage, see our laboratory supplies.
For laboratory research use only. Not for human or veterinary use. Not a medicine, food, supplement or cosmetic.
Reviews
There are no reviews yet.